| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8cf70025d669eddf0c9c56847266f03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a073d0e888c536b01f8a0e9c0ec9e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16bf8d4d67c58aa34566609c5969fdff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3baafd1a94e399da6b1acbd2a0d2f52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89ff76321b6aeb23fcadf5ef8fccaa63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c00afb8896c3f72e27470d922827f9d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb49c80af07da7db28235693afee8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5057762534886bb436e7d79c87fc88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04beebf903ef9e0b34b2c1b6e2640816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065bc4e8d53e6d92192d8e3b5a4ef32f |
| publicationDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9663516-B2 |
| titleOfInvention |
Bicyclic-pyrimidinedione compounds |
| abstract |
The present invention provides novel bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472796-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836755-B2 |
| priorityDate |
2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |